The epidemiological impact of childhood influenza vaccination using live-attenuated influenza vaccine (LAIV) in Germany: predictions of a simulation study
Markus A. Rose(Goethe University Frankfurt), Martin Eichner(University Hospital Cologne), Markus Schwehm(MorphoSys (Germany)), Oliver Damm(Bielefeld University), Markus Knuf(Helios Kliniken), H. Krüger(Pfizer (Germany)), Thomas F Kochmann, Peter Wutzler(Jena University Hospital), U. Wahn(Charité - Universitätsmedizin Berlin), Wolfgang Greiner(Bielefeld University), Tom Schaberg(Saxon Police Force), Johannes G. Liese(Universitätsklinikum Würzburg)
Cited by 47
Related Papers
Barriers and Strategies in Guideline Implementation—A Scoping Review
|Healthcare|2016|946
Development of the EQ-5D-Y: a child-friendly version of the EQ-5D
|Quality of Life Research|2010|903
German Value Set for the EQ-5D-5L
|PharmacoEconomics|2018|618
Feasibility, reliability, and validity of the EQ-5D-Y: results from a multinational study
|Quality of Life Research|2010|476
A single European currency for EQ-5D health states
|The European Journal of Health Economics|2003|465